Legacy Wealth Asset Management, LLC Biogen Inc. Transaction History

Legacy Wealth Asset Management, LLC

$331 Million
Q2 2025

A detailed history of Legacy Wealth Asset Management, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Legacy Wealth Asset Management, LLC holds 2,511 shares of BIIB stock, worth $401,458. This represents 0.1% of its overall portfolio holdings.

Number of Shares

2,511

Previous 2,420 3.76%

Holding current value

$401,458

Previous $331,000 4.83%

% of portfolio

0.1%

Previous 0.1%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 30, 2025	BUY	$113.38 - $135.49 $10,317 - $12,329	91 Added 3.76%	2,511 $315,000
Q1 2025 Apr 08, 2025	BUY	$133.43 - $153.27 $78,857 - $90,582	591 Added 32.31%	2,420 $331,000
Q4 2024 Jan 14, 2025	SELL	$146.47 - $191.55 $50,825 - $66,467	-347 Reduced 15.95%	1,829 $279,000
Q3 2024 Oct 23, 2024	BUY	$189.07 - $236.8 $16,260 - $20,364	86 Added 4.11%	2,176 $421,000
Q2 2024 Aug 14, 2024	BUY	$190.52 - $236.72 $17,527 - $21,778	92 Added 4.6%	2,090 $484,000
Q1 2024 Apr 19, 2024	BUY	$212.02 - $267.71 $16,325 - $20,613	77 Added 4.01%	1,998 $430,000
Q4 2023 Jan 10, 2024	SELL	$222.59 - $267.94 $2,225 - $2,679	-10 Reduced 0.52%	1,921 $497,000
Q3 2023 Oct 31, 2023	BUY	$253.3 - $285.89 $8,105 - $9,148	32 Added 1.69%	1,931 $496,000
Q2 2023 Aug 04, 2023	SELL	$275.25 - $318.06 $550,500 - $636,120	-2,000 Reduced 51.3%	1,899 $540,000
Q1 2023 Apr 21, 2023	SELL	$256.56 - $292.34 $12,058 - $13,739	-47 Reduced 1.19%	3,899 $1.08 Million
Q4 2022 Feb 02, 2023	SELL	$252.44 - $306.72 $37,108 - $45,087	-147 Reduced 3.59%	3,946 $1.09 Million
Q3 2022 Oct 14, 2022	BUY	$194.69 - $268.46 $158,477 - $218,526	814 Added 24.82%	4,093 $1.09 Million
Q2 2022 Jul 19, 2022	BUY	$187.54 - $223.02 $13,127 - $15,611	70 Added 2.18%	3,279 $669,000
Q1 2022 May 12, 2022	BUY	$193.77 - $244.14 $79,833 - $100,585	412 Added 14.73%	3,209 $676,000
Q4 2021 Feb 10, 2022	BUY	$223.92 - $287.77 $66,280 - $85,179	296 Added 11.84%	2,797 $671,000
Q3 2021 Oct 19, 2021	BUY	$282.99 - $369.05 $3,678 - $4,797	13 Added 0.52%	2,501 $708,000
Q2 2021 Jul 14, 2021	BUY	$259.0 - $414.71 $21,238 - $34,006	82 Added 3.41%	2,488 $862,000
Q1 2021 Apr 20, 2021	BUY	$242.95 - $284.63 $18,950 - $22,201	78 Added 3.35%	2,406 $673,000
Q4 2020 Mar 25, 2021	BUY	$236.26 - $355.63 $550,013 - $827,906	2,328 New	2,328 $570,000

Others Institutions Holding BIIB

# of Institutions

1,020

Shares Held

131M

Call Options Held

2.87M

Put Options Held

2.57M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $23B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Wealth Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legacy Wealth Asset Management, LLC with notifications on news.

Account

Legacy Wealth Asset Management, LLC Biogen Inc. Transaction History